Results 21 to 30 of about 178,635,816 (158)

HN1L promotes invasion and metastasis of the esophagogastric junction adenocarcinoma

Thoracic Cancer, 2021
Background Adenocarcinoma of the esophagogastric junction (AEG) refers to cancer that crosses the line of the gastroesophageal junction and includes distal esophageal cancer and proximal gastric cancer.
Zhao Yang Wang, Wen Xiao, Yuan Zhu Jiang, Wei Dong, Xiang Wei Zhang, Lin Zhang   +5 more
doaj   +1 more source

The Contribution of the Left Phrenic Nerve to Innervation of the Esophagogastric Junction [PDF]

, 2020
The contribution of the left phrenic nerve to innervation of the esophagogastric junction. The esophagogastric junction is part of the barrier preventing gastroesophageal reflux.
Djonov, Valentin, Herrmann, Gudrun, Draeger, Annette, Gudrun Herrmann, Haenssgen, Kati, Manfred Essig, Kati Haenssgen, Valentin Djonov, Essig, Manfred, Annette Draeger   +9 more
core   +2 more sources

Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis

BMC Surgery, 2021
Background To analyze whether neoadjuvant chemoradiotherapy (nCRT) could improve the survival for patients with adenocarcinoma of the esophagogastric junction compared with neoadjuvant chemotherapy (nCT).
Jing Li, Qun Zhao, Xueke Ge, Yuzhi Song, Yuan Tian, Shuoshuo Wang, Ming Liu, Xueying Qiao   +7 more
doaj   +1 more source

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction [PDF]

, 2013
Background: This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) of neoadjuvant radiochemotherapy (RCT) with docetaxel and oxaliplatin in patients with locally advanced adenocarcinoma of the oesophagogastric ...
Klautke, Gunther, Galle, Peter R., Brenner, Baruch, Arnold, Dirk, Roessler, Hans-Peter, Thomaidis, Thomas, Schimanski, Carl Christoph, Schmidberger, Heinz, Rödel, Claus, Gockel, Ines, Möhler, Markus, Trarbach, Tanja, Lang, Hauke   +12 more
core   +1 more source

Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT

BMC Cancer, 2019
Background The prognosis of patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma is still dismal. There are no standard treatment strategies for these patients.
Xiaowen Liu, Jiejie Jin, Hong Cai, Hua Huang, Guangfa Zhao, Ye Zhou, Jianghong Wu, Chunyan Du, Ziwen Long, Yantian Fang, Mingze Ma, Guichao Li, Menglong Zhou, Jiliang Yin, Xiaodong Zhu, Ji zhu, Weiqi Sheng, Dan Huang, Hui Zhu, Zhaozhen Zhang, Qi Lu, Li Xie, Zhen Zhang, Yanong Wang   +23 more
doaj   +1 more source

A unique case of esophageal carcinosarcoma with histopathological diversities

Human Pathology: Case Reports, 2019
We report a 57-year-old Japanese male with esophageal carcinosarcoma with histopathological diversities. The patient complained of dysphagia.
Shohei Matsuo, MD, Yoshiki Nakamura, MD, PhD, Motoki Hiroyoshi, MD, PhD, Ken-ichi Tomiyama, MD, PhD, Terumasa Sashikata, MD, PhD, Nobuyuki Kondo, MD, PhD, Yoshitane Tsukamoto, MD, PhD   +6 more
doaj   +1 more source

Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study

World Journal of Surgical Oncology, 2020
Background The prognosis of adenocarcinoma of the esophagogastric junction (AEG) is poor. Understanding the postoperative recurrence pattern of AEG is helpful to verify the effectiveness of treatment and optimize subsequent treatment, so as to improve ...
Haitao Xu, Lianguo Zhang, Jing Miao, Shuai Liu, Hongjian Liu, Teng Jia, Qingguang Zhang   +6 more
doaj   +1 more source

The Value of Predicting Human Epidermal Growth Factor Receptor 2 Status in Adenocarcinoma of the Esophagogastric Junction on CT-Based Radiomics Nomogram

Frontiers in Oncology, 2021
PurposeWe developed and validated a CT-based radiomics nomogram to predict HER2 status in patients with adenocarcinoma of esophagogastric junction (AEG).MethodA total of 101 patients with HER2-positive (n=46) and HER2-negative (n=55) esophagogastric ...
Shuxing Wang, Yiqing Chen, Han Zhang, Zhiping Liang, Jun Bu   +4 more
doaj   +1 more source

A case of superficial spreading type of poorly differentiated adenocarcinoma of the stomach with invasion to the esophagus

World Journal of Surgical Oncology, 2022
Background Invasion is more likely to occur in gastric cancer affecting larger areas. Poorly differentiated adenocarcinoma tends to invade deep. The cardiac region prefers submucosal invasion because the submucosa is coarser than the other regions.
Junichi Mase, Takahito Adachi, Shunya Kiriyama, Takeshi Horaguchi, Kazunori Yawata, Aiko Ikawa, Bun Sano, Susumu Imai, Kiyohisa Okamoto, Takashi Shiroko   +9 more
doaj   +1 more source

A neuroendocrine carcinoma with a well-differentiated adenocarcinoma component arising in Barrett’s esophagus: a case report and literature review

Surgical Case Reports, 2018
Background An esophageal neuroendocrine carcinoma arising in Barrett’s esophagus is extremely rare. Here, we report a case of an esophageal neuroendocrine carcinoma with a well-differentiated adenocarcinoma component arising in Barrett’s esophagus and ...
Shunsuke Doi, Sohei Matsumoto, Kohei Wakatsuki, Kazuhiro Migita, Masahiro Ito, Tomohiro Kunishige, Hiroshi Nakade, Kinta Hatakeyama, Chiho Ohbayashi, Masayuki Sho   +9 more
doaj   +1 more source